Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cystic fibrosis
Biotech
As pharma eyes shiny obesity drugs, Vertex tops orphan drug list
Vertex’s cystic fibrosis triple combo is the top orphan pipeline drug, amid shifting sentiments in the pharma industry for rare disease drugs.
Annalee Armstrong
Apr 24, 2024 12:01am
Europe leads in cystic fibrosis trials, North America for AML
Apr 16, 2024 5:00pm
BiomX acquires fellow bacteria-killing virus company APT
Mar 6, 2024 9:01am
Sionna adds $182M to extend pipeline, cash runway through 2026
Mar 6, 2024 8:00am
Vertex meets own cystic fibrosis record with next-gen treatment
Feb 5, 2024 7:50pm
Carl June, Vertex execs among 2024's Breakthrough Prize winners
Sep 15, 2023 8:00am